New Tool Shows Promise For Studying Relapse Of Malaria

Vaccine News Daily: New tool for studying relapsing malaria infections
“A new tool could be instrumental in transforming the medical community’s search for novel treatments against relapsing malaria infections. Researchers at Seattle BioMed recently used a human-chimeric mouse model to further study Plasmodium vivax malaria parasite liver infections. The scientists used this tool to grow livers from humans. They then infect[ed] the livers with P. vivax to investigate the parasite’s activity, development, and dormancy…” (4/1).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.